Published in:
Open Access
01-12-2011 | Poster presentation
Safety and feasibility of high dose stress dobutamine mri very early after acute myocardial infarction
Authors:
Michael Mamone, Stephanie Lehrke, Dirk Lossnitzer, Grigorios Korosoglou, Evangelos Giannitsis, Hugo A Katus, Henning Steen
Published in:
Journal of Cardiovascular Magnetic Resonance
|
Special Issue 1/2011
Login to get access
Excerpt
Dobutamine stress studies after acute ST or Non-ST elevation myocardial infarction (STEMI, NSTEMI, AMI) have prognostic implications for future cardiovascular events and therefore have an impact on the indicated therapy by identifying high-risk patients. Dobutamine side effects early after AMI have been extensively reported. Namely malignant arrhythmias are feared, since mostly the initiated beta blocker therapy was interrupted for stress studies to achieve the required sub-maximal heart rate increase. …